• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Catalog Number UNK CDS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Endocarditis (1834); Fever (1858); Mitral Regurgitation (1964); Tissue Damage (2104); Weakness (2145)
Event Date 12/01/2013
Event Type  Injury  
Manufacturer Narrative
Dates of event and implant: dates estimated.Udi number is unknown as the part and lot number were not provided.The device remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This will be filed to report post mitraclip procedure, the patient presented with recurrent mr, tissue damage and endocarditis it was reported through a case study which identifies a woman which had a mitraclip procedure to treat nyha iii - iv.Post interventional procedure the nyha state immediately recovered to nyha i.Residual permissive mitral valve incompetence i-ii was classified as an excellent result after mitraclip procedure.Five weeks later the patient felt weak, had fever and returned to nyha iv again.The echocardiography showed ruptured chordae and adherent material on the clip.No cerebral event has occurred so far.Based on the diagnosis of a mitral valve endocarditis after mitraclip with an acute mitra valve insufficiency urgent surgical procedure was required.The intraoperative findings showed an almost completely destroyed mitral valve.The mitraclip device performed perforation in the annulus of mitral valve and chordae were ruptured.Too little left native valve texture was insufficient for any techniques of mitral valve repair.For that reason there had to be a mitral valve replacement with a biological prosthesis.Perioperative course and 1 year follow-up was reported uneventful.Details are listed in the attached article, mitral valve repair: infective endocarditis after mitralclip.No additional information was provided.
 
Manufacturer Narrative
Date estimated.The clip remains implanted.A review of the lot history record could not be performed as the part and lot information regarding the complaint device was not provided.A definitive cause for the reported patient effect of mitral regurgitation, tissue damage, endocarditis, fever, and weakness could not be determined.The reported patient effects of mitral regurgitation, tissue damage, endocarditis, as listed in the mitraclip system instructions for use (ifu), are known possible complications associated with mitraclip procedures.There is no indication of a product issue with respect to manufacture, design, or labeling.
 
Manufacturer Narrative
This report is being resubmitted to ensure the enclosed attachment can be easily opened by the fda.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM CLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9823943
MDR Text Key184759409
Report Number2024168-2020-02316
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup,Followup
Report Date 07/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK CDS
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/18/2020
Initial Date FDA Received03/12/2020
Supplement Dates Manufacturer Received04/03/2020
07/20/2020
Supplement Dates FDA Received04/17/2020
07/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
-
-